Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease

Eye (Lond). 2009 Mar;23(3):742-3. doi: 10.1038/eye.2008.99. Epub 2008 Apr 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Chemotherapy, Adjuvant / adverse effects
  • Diabetes Mellitus, Type 1 / complications
  • Diabetic Retinopathy / drug therapy*
  • Humans
  • Retinal Perforations / chemically induced*
  • Vitrectomy

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab